TickerFacts.

Compare

PetMed Express Inc vs CVS Health Corp

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearPetMed Express Inc
PETS		CVS Health Corp
CVS
Year ended2026-03-312025-12-31
Revenue$179.02M$402.07B
Revenue growth (YoY)-21.1%+7.8%
Gross margin28.1%n/a
Operating margin-32.8%1.2%
Net margin-32.0%0.4%
Net income-$57.29M$1.73B
EPS (Diluted)-$2.74$1.39
Operating cash flow-$28.39M$10.64B
Free cash flow-$33.01M$7.81B
Cash & equivalents$21.41M$8.45B
Total assets$81.19M$253.54B
Total liabilities$52.25M$178.16B
Shareholders' equity$28.94M$75.21B
Return on year-end equity-197.9%2.3%
Shares outstanding21.39M1.27B

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearPetMed Express IncCVS Health Corp
Latest$179.02M
Ended 2026-03-31		$402.07B
Ended 2025-12-31
1 year earlier$226.97M
Ended 2025-03-31		$372.81B
Ended 2024-12-31
2 years earlier$274.10M
Ended 2024-03-31		$357.78B
Ended 2023-12-31
3 years earlier$247.57M
Ended 2023-03-31		$322.47B
Ended 2022-12-31
4 years earliern/a$292.11B
Ended 2021-12-31